GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Change In Receivables

Kineta (STU:J75) Change In Receivables : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Change In Receivables?

Kineta's change in receivables for the quarter that ended in Jun. 2024 was €0.00 Mil. It means Kineta's Accounts Receivable stayed the same from Mar. 2024 to Jun. 2024 .

Kineta's change in receivables for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means Kineta's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Kineta's Accounts Receivable for the quarter that ended in Jun. 2024 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kineta's liquidation value for the three months ended in Jun. 2024 was €-7.88 Mil.


Kineta Change In Receivables Historical Data

The historical data trend for Kineta's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Change In Receivables Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Receivables
- - - -

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kineta Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta  (STU:J75) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kineta's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

2. In Ben Graham's calculation of liquidation value, Kineta's accounts receivable are only considered to be worth 75% of book value:

Kineta's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.836-8.712+0.75 * 0+0.5 * 0
=-7.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kineta's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta Business Description

Traded in Other Exchanges
Address
7683 SE 27th Street, Suite 481, Mercer Island, WA, USA, 98040
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta Headlines

No Headlines